Source study found
Story checked
The Vivid Dreams Stage of REM Sleep Is Linked With a Lower Risk of 83 Diseases : ScienceAlert (opens in a new tab)
sciencealert.com · 2026-09-21
Short answer
MixedMixed.
The claims we could check match the study, but some claims were not covered by the evidence reviewed.
- 3 supported
- 5 not covered
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
The Vivid Dreams Stage of REM Sleep Is Linked With a Lower Risk of 83 Diseases : ScienceAlert
sciencealert.com · 2026-09-21
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Mixed
Every claim we could check holds up. Three of eight claims match the study. This overall rating is based only on the claims we could check. Five claims the study doesn't address.
- 3 supported
- 5 not covered
The source study
Accelerometer-derived real-world sleep stages and risk of incident diseases: A UK Biobank cohort study and phenome-wide association analysis
Evidence layer
Claim by claim
Each claim gets a verdict. Expand it to see the evidence directly below.
Reading mode
Scan verdicts. Open evidence only when needed.
Browse by verdict
8 claims in this storyShowing all 8 claimsChoose a verdict to focus the list.
Claim 1 of 8Not coveredA new study in PLOS Medicine led by researchers from Capital Medical University in China analyzed data from 95,559 participants in a UK health project.View evidenceHide evidence
As stated95,559 participants
Why this verdict
The supplied abstract-level profile supports the UK Biobank cohort size of 95,559 participants and wrist-accelerometer-based analysis, but it does not verify the journal name, publication framing as 'new,' or Capital Medical University lead authorship. Those bibliographic/affiliation details are not available in the supplied profile.
Study evidence
Overall variation in accelerometer-derived sleep patterns was associated with incidence of 156 diseases across the phenome.156 disease associations identified (direction and magnitude varied by exposure and outcome)
“we analyzed wrist-worn accelerometer data from 95,559 Biobank participants and derived key metrics of real-world sleep patterns: rapid eye movement [REM], N1, N2, and N3; total sleep duration; sleep irregularity; and wakefulness after sleep onset using the SleepNet algorithm.”
Claim 2 of 8Not coveredWrist-worn trackers were used to map a week of sleep patterns against over a thousand health conditions, with a median follow-up of almost nine years.View evidenceHide evidence
As stateda week of sleep patterns; over a thousand health conditions; almost nine years
Why this verdict
The profile supports wrist-worn accelerometry, 1,049 health outcomes, and median follow-up of 8.9 years. However, the supplied abstract-level profile does not state that the wrist-tracker sleep measurement covered 'a week,' so the claim as phrased is not fully verifiable at this depth.
Study evidence
Overall variation in accelerometer-derived sleep patterns was associated with incidence of 156 diseases across the phenome.156 disease associations identified (direction and magnitude varied by exposure and outcome)
“we analyzed wrist-worn accelerometer data from 95,559 Biobank participants and derived key metrics of real-world sleep patterns: rapid eye movement [REM], N1, N2, and N3; total sleep duration; sleep irregularity; and wakefulness after sleep onset using the SleepNet algorithm.”
Claim 3 of 8Not coveredMore REM sleep was associated with a lower risk of dozens of diseases, including heart failure, Alzheimer's disease, hypotension, and atrial fibrillation.View evidenceHide evidence
As stated83 diseases
Why this verdict
The association between greater REM sleep and lower risk for 83 diseases is supported. But the supplied abstract-level profile says the specific diseases are not enumerated in the abstract, so the listed examples—heart failure, Alzheimer's disease, hypotension, and atrial fibrillation—cannot be verified from the supplied evidence.
Study evidence
Overall variation in accelerometer-derived sleep patterns was associated with incidence of 156 diseases across the phenome.156 disease associations identified (direction and magnitude varied by exposure and outcome)
“we analyzed wrist-worn accelerometer data from 95,559 Biobank participants and derived key metrics of real-world sleep patterns: rapid eye movement [REM], N1, N2, and N3; total sleep duration; sleep irregularity; and wakefulness after sleep onset using the SleepNet algorithm.”
Claim 4 of 8Not coveredThe story says deep sleep was associated with lower risk for some conditions such as type 2 diabetes and Parkinson's disease.View evidenceHide evidence
Why this verdict
The profile supports the general finding that greater deep sleep was associated with lower risk for 7 diseases. However, the abstract-level profile explicitly does not provide the identities of those diseases, so type 2 diabetes and Parkinson's disease cannot be verified from the supplied evidence.
Study evidence
Overall variation in accelerometer-derived sleep patterns was associated with incidence of 156 diseases across the phenome.156 disease associations identified (direction and magnitude varied by exposure and outcome)
“we analyzed wrist-worn accelerometer data from 95,559 Biobank participants and derived key metrics of real-world sleep patterns: rapid eye movement [REM], N1, N2, and N3; total sleep duration; sleep irregularity; and wakefulness after sleep onset using the SleepNet algorithm.”
Claim 5 of 8Not coveredThe article stresses that the study does not prove direct cause and effect and that more work is needed to understand whether REM sleep acts through distinct biological pathways.View evidenceHide evidence
Why this verdict
The no-cause-and-effect caveat is supported by the profile's limitation that the observational design does not permit causal inference. But the supplied abstract-level profile does not include the proposed idea that REM sleep may act through distinct biological pathways, so that part is not verifiable at this depth.
Study evidence
Overall variation in accelerometer-derived sleep patterns was associated with incidence of 156 diseases across the phenome.156 disease associations identified (direction and magnitude varied by exposure and outcome)
“we analyzed wrist-worn accelerometer data from 95,559 Biobank participants and derived key metrics of real-world sleep patterns: rapid eye movement [REM], N1, N2, and N3; total sleep duration; sleep irregularity; and wakefulness after sleep onset using the SleepNet algorithm.”
Claim 6 of 8SupportedREM sleep stood out as the sleep stage most linked to health differences in the study.View evidenceHide evidence
Why this verdict
The profile reports that higher REM sleep was associated with lower risks for 83 diseases, more than the reported disease counts for deep sleep, sleep irregularity, or WASO. Framing REM as the sleep stage that 'stood out' is consistent with the abstract-level findings.
Study evidence
Overall variation in accelerometer-derived sleep patterns was associated with incidence of 156 diseases across the phenome.156 disease associations identified (direction and magnitude varied by exposure and outcome)
“we analyzed wrist-worn accelerometer data from 95,559 Biobank participants and derived key metrics of real-world sleep patterns: rapid eye movement [REM], N1, N2, and N3; total sleep duration; sleep irregularity; and wakefulness after sleep onset using the SleepNet algorithm.”
Claim 7 of 8SupportedThe researchers wrote that higher amounts of REM sleep and deep sleep were associated with lower risks of 83 and 7 diseases, respectively, while greater sleep irregularity and increased wake after sleep onset were linked to elevated risks of 3 and 6 diseases, respectively.View evidenceHide evidence
As stated83, 7, 3, and 6 diseases
Why this verdict
The claim closely matches the abstract-level results: higher REM sleep was associated with lower risks for 83 diseases, higher deep sleep for 7 diseases, greater sleep irregularity with elevated risk for 3 diseases, and increased WASO with elevated risk for 6 diseases. It is framed associationally rather than causally.
Study evidence
Overall variation in accelerometer-derived sleep patterns was associated with incidence of 156 diseases across the phenome.156 disease associations identified (direction and magnitude varied by exposure and outcome)
“we analyzed wrist-worn accelerometer data from 95,559 Biobank participants and derived key metrics of real-world sleep patterns: rapid eye movement [REM], N1, N2, and N3; total sleep duration; sleep irregularity; and wakefulness after sleep onset using the SleepNet algorithm.”
Claim 8 of 8SupportedSleeping six to eight hours a night seemed to be a 'sweet spot' associated with a lower risk of a significant number of diseases, while sleeping less than five hours was associated with a higher risk of 37 diseases compared with six to eight hours.View evidenceHide evidence
As stated6–8 hours; less than 5 hours; 37 diseases
Why this verdict
The profile supports nonlinear sleep-duration findings in which minimum-risk sleep durations for 69 phenotypes were predominantly within 6–8 hours, and a category-specific analysis in which extreme short sleep under 5 hours accounted for 37 of 41 significant adverse associations compared with the 6–8 hour reference. The story's hedged 'seemed to be' wording keeps the 'sweet spot' framing associational.
Study evidence
RCS analyses identified significant non-linear relationships between sleep duration and incident disease for 86 phenotypes (P for nonlinear < 0.05).
“Phenome-wide association analysis and restricted cubic spline (RCS) analyses were performed using Cox proportional hazard regression...”
Study evidence
Extreme short sleep (<5 hours) exhibited the most widespread adverse disease-association pattern versus the 6–8 hour reference.37 of 41 significant adverse associations (count) attributed to <5h group vs 6–8h reference
“In the category-specific analysis, individuals with extreme short sleep (<5 hours) exhibited the most widespread clinical vulnerabilities, accounting for 37 of the 41 identified significant adverse associations compared to the 6-8 hours reference group.”
Context layer
What the story left out
Important study details the story did not include.
Residual confounding remains a material limitation of the observational cohort design.
The story mentions lack of causal proof but, based on the supplied caveats, does not explicitly convey residual confounding as a reason the associations could be distorted.
From Prospective cohort (UK Biobank) observational analysis; restricted cubic spline dose–response within Cox proportional ha
The sleep measures were derived from wrist accelerometry and SleepNet rather than direct polysomnography, leaving potential measurement or classification limitations.
The story notes the use of real-world tracker data rather than self-report, but the supplied caveats do not mention algorithm-derived sleep staging or possible measurement/classification error.
From Prospective cohort (UK Biobank) observational analysis; restricted cubic spline dose–response within Cox proportional ha
8 things the story did carry across
- The paper is a prospective observational UK Biobank cohort analysis using wrist-worn accelerometer data from 95,559 participants.
- Sleep stages and sleep-pattern metrics were algorithm-derived from accelerometer data, including REM, N1, N2, N3/deep sleep, total sleep duration, sleep irregularity, and wakefulness after sleep onset.
- The study mapped associations across 1,049 incident health outcomes using adjusted Cox proportional hazards models over a median 8.9 years of follow-up.
- Higher REM sleep was associated with lower risk for 83 diseases, making it the most prominent reported sleep-stage association in the abstract.
- Higher deep sleep was associated with lower risk for 7 diseases; greater sleep irregularity and increased WASO were associated with elevated risks for 3 and 6 diseases, respectively.
- Restricted cubic spline analyses found nonlinear sleep-duration associations, with minimum-risk sleep durations predominantly in the 6–8 hour range for many phenotypes.
- Category-specific analyses found that extreme short sleep under 5 hours had the broadest adverse pattern, with 37 of 41 significant adverse associations versus a 6–8 hour reference.
- The observational design limits causal inference.
Study layer
Study at a glance
Scan the study first. Expand only the parts you want to inspect.
Pieces of work
3
Evidence read
study summary
Lead result
secondary data
1Lead resultsecondary dataCreate an atlas (phenome-wide map) of associations between accelerometer-derived real-world sleep stages/pattern metrics and risk of incident diseases in UK Biobank.Prospective cohort (UK Biobank) observational analysisExpandCollapse
In plain English
Prospective phenome-wide cohort analysis in UK Biobank (n=95,559) using wrist accelerometer data processed with the SleepNet algorithm to derive sleep stages (REM, N1, N2, N3) and pattern metrics (total sleep duration, sleep irregularity, WASO), relating these exposures to incidence of 1,049 disease outcomes using adjusted Cox proportional hazards models and spline/category-specific analyses over a median 8.9-year follow-up.
Key findings
- Overall variation in accelerometer-derived sleep patterns was associated with incidence of 156 diseases across the phenome.156 disease associations identified (direction and magnitude varied by exposure and outcome)
- Greater REM sleep amount was associated with lower risk for multiple diseases.Lower risks for 83 diseases associated with higher REM sleep (counts reported in abstract)
“we analyzed wrist-worn accelerometer data from 95,559 Biobank participants and derived key metrics of real-world sleep patterns: rapid eye movement [REM], N1, N2, and N3; total sleep duration; sleep irregularity; and wakefulness after sleep onset using the SleepNet algorithm.”
What this piece can’t prove
- Observational cohort design; susceptible to residual confounding and does not permit causal inference (stated as main limitation in abstract).
2secondary dataCharacterize (and test for) non-linear dose–response relationships between sleep duration (and related sleep metrics) and incident disease risk, including identification of minimum-risk sleep-duration ranges (e.g., 6–8 hours).restricted cubic spline dose–response within Cox proportional hazards modelsExpandCollapse
In plain English
Within a UK Biobank cohort (n=95,559, median follow-up 8.9 years), the authors used restricted cubic spline (RCS) models implemented in Cox proportional hazards regression to test for non-linear dose–response relationships between accelerometer-derived sleep duration (hours) and incidence of 1,049 disease phenotypes. RCS analyses identified significant non-linear associations for 86 phenotypes (P for nonlinear < 0.05) and estimated minimum-risk sleep-duration windows for 69 phenotypes that were predominantly concentrated in the 6–8 hours range.
Key findings
- RCS analyses identified significant non-linear relationships between sleep duration and incident disease for 86 phenotypes (P for nonlinear < 0.05).
- Estimated minimum-risk sleep-duration windows were concentrated in the 6–8 hours range for 69 phenotypes with nonlinear associations.
“Phenome-wide association analysis and restricted cubic spline (RCS) analyses were performed using Cox proportional hazard regression...”
What this piece can’t prove
- Observational cohort design limits causal inference and remains susceptible to residual confounding (noted by authors).
- Abstract lacks detail on spline specification (knot number/placement), covariate sets for each spline model, and multiple-testing correction strategy.
- Measurement limitations: accelerometer-derived sleep-duration estimates and derived sleep metrics may have classification error relative to polysomnography.
1 further detail could not be confirmed from the summary.
3secondary dataCompare disease-risk associations across sleep-duration categories (e.g., extreme short sleep <5h versus 6–8h reference) to identify which categories show the broadest clinical vulnerability.secondary data cohort categorical exposure phenome-wide analysisExpandCollapse
In plain English
In a category-specific analysis of accelerometer-derived sleep duration in UK Biobank participants, individuals with extreme short sleep (<5 hours) showed the broadest pattern of adverse incident-disease associations: 37 of 41 identified significant adverse associations were attributed to the <5h group versus the 6–8h reference.
Key findings
- Extreme short sleep (<5 hours) exhibited the most widespread adverse disease-association pattern versus the 6–8 hour reference.37 of 41 significant adverse associations (count) attributed to <5h group vs 6–8h reference
“In the category-specific analysis, individuals with extreme short sleep (<5 hours) exhibited the most widespread clinical vulnerabilities, accounting for 37 of the 41 identified significant adverse associations compared to the 6-8 hours reference group.”
What this piece can’t prove
- Observational design susceptible to residual confounding and does not permit causal inference (as stated by the authors).
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Accelerometer-derived real-world sleep stages and risk of incident diseases: A UK Biobank cohort study and phenome-wide association analysis
PLoS medicine · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
PubMed, Europe PMC, Crossref · 15 candidate papers
Accelerometer-derived real-world sleep stages and risk of incident diseases: A UK Biobank cohort study and phenome-wide association analysis
PLoS Medicine · 2026 · PubMed, Europe PMC, Crossref
Accelerometry-Derived REM Sleep Behavior Disorder Predicts Future Parkinson’s Disease in the UK Biobank
2026 · Crossref
Associations Between Accelerometer-Assessed Sleep Patterns, Proteomic Signatures, and Hallmarks of Aging in Adulthood.
Aging Cell · 2026 · PubMed
0807 Associations Between Accelerometry-assessed Sleep Patterns and Hallmarks of Aging in the UK Biobank
SLEEPJ · 2026 · Crossref
Wearable Movement-Tracking for Prodromal Parkinson's Disease Detection: A Cross-Country Validation Study.
Movement Disorders : Official Journal of the Movement Disorder Society · 2026 · PubMed
Accelerometer-derived sleep onset timing and cardiovascular disease incidence: a UK Biobank cohort study
European Heart Journal - Digital Health · 2021 · Crossref
And 9 more candidates considered.